NCT07262840

Brief Summary

Background Colorectal cancer is a significant health concern. For individuals identified as being at high risk for developing this disease, adopting healthy lifestyle behaviors is a powerful way to lower that risk. However, starting and maintaining these new habits can be challenging. This study aims to test a comprehensive support program designed to help high-risk individuals make and sustain these positive health behavior changes. Purpose The main goal of this research is to see if a specially designed 12-week health promotion program can effectively help high-risk individuals improve their lifestyle (e.g., diet, exercise, smoking/alcohol use), increase their knowledge about colorectal cancer, and strengthen their confidence and motivation to stay healthy. Study Groups Participants in this study will be randomly assigned (like flipping a coin) to one of two groups:

  • Educational Workshops: Five in-person group sessions to learn about cancer prevention, create personal health plans, and solve problems with others.
  • Online Support: Regular health articles and tips sent through a private WeChat group.
  • Daily Check-ins: Using the WeChat group for simple daily check-ins on exercise, fruit/vegetable intake, and smoking/alcohol use to build habit.
  • Peer Support: Being paired with a "health buddy" and interacting with other participants for motivation. All participants will be asked to complete several questionnaires at the beginning of the study, during the program, and after it ends (at 3 months) to measure their knowledge, beliefs, and lifestyle habits. Duration The active program lasts for 12 weeks. Potential Benefits Participants in the Intervention Group may benefit from improved health habits, a better understanding of how to reduce their cancer risk, and increased social support. Participants in the control group will receive general health information. If they wish, they will receive the same health materials and behavioral change intervention as the intervention group after the intervention concludes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

November 19, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2026

Completed
Last Updated

December 4, 2025

Status Verified

November 1, 2025

Enrollment Period

3 months

First QC Date

November 19, 2025

Last Update Submit

November 28, 2025

Conditions

Keywords

Health Promotion;Health Behavior;Lifestyle Intervention;High-Risk Population

Outcome Measures

Primary Outcomes (1)

  • Score change in the Health Promotion Lifestyle Scale for High-Risk Colorectal Cancer Population (HPLP-HRCP)

    This is the primary outcome measure, assessed using the revised Health Promotion Lifestyle Profile for High-Risk Colorectal Cancer Population (HPLP-HRCP). This scale measures the level of health-promoting lifestyle behaviors. A higher total score indicates a better health-promoting lifestyle.

    Baseline (Week 0), Post-intervention (Week 12)

Secondary Outcomes (5)

  • Score change in Colorectal Cancer Knowledge Questionnaire (CRC-KQ)

    Baseline (Week 0), Post-intervention (Week 12).

  • Score change in the Champion Health Belief Model Scale (CHBMS)

    Baseline (Week 0), Post-intervention (Week 12).

  • Score change in the Multidimensional Health Locus of Control Scale (MHLC)

    Baseline (Week 0), Post-intervention (Week 12).

  • Score change in the Kessler Psychological Distress Scale (K10)

    Baseline (Week 0), Post-intervention (Week 12).

  • Score change in the Perceived Social Support Scale (PSSS)

    Baseline (Week 0), Post-intervention (Week 12).

Study Arms (2)

Health Promotion Lifestyle Intervention Group

EXPERIMENTAL

Participants in this arm receive a 12-week, multi-component health promotion program based on the Health Promotion Model. The intervention includes: 1) Five in-person group workshops focusing on knowledge, motivation, planning, and maintenance; 2) Online support via a WeChat group for daily behavioral check-ins (e.g., exercise, diet) and peer support; 3) Educational articles and resources; 4) Techniques from Motivational Interviewing and Acceptance and Commitment Therapy to foster psychological adjustment and behavior change.

Behavioral: Multi-component Health Promotion Lifestyle Intervention

Standard Care

ACTIVE COMPARATOR

Participants in this arm receive standard care, which may include general health information about colorectal cancer prevention. They do not participate in the structured workshops, online check-ins, or specialized support of the experimental intervention. They will complete all the same assessment questionnaires as the intervention group. They may be offered the intervention program after the study is complete (wait-list design).

Other: Standard Care

Interventions

1. Intervention Name: Multi-Component Health Promotion Lifestyle Intervention 2. Description: This is a structured, theory-based intervention designed to facilitate health behavior change in individuals at high risk for colorectal cancer. It is distinguished by its foundation in the Health Promotion Model and the Integrative Model of Health Behavior Change, and its use of a blended online and offline delivery model over a 12-week period. The intervention is organized into five sequential modules: Cognitive Reconstruction: Provides essential knowledge about colorectal cancer (etiology, risk factors) and disease prevention strategies. Psychological Adjustment: Employs techniques from Motivational Interviewing to build intrinsic motivation and Acceptance and Commitment Therapy (ACT) to help participants manage distress and psychological barriers related to their cancer risk. Health Behavior Establishment: Guides participants in creating personalized health plans and builds self-effic

Health Promotion Lifestyle Intervention Group

Participants randomised to the control arm will receive standard care, which may include general health advice or publicly available educational pamphlets on colorectal cancer prevention. They will not receive any component of the structured multi-component health promotion lifestyle intervention (i.e., no group workshops, no WeChat-based check-ins, no psychological techniques training, and no facilitated peer support). However, they will be asked to complete all the same assessment questionnaires at the same time points as the intervention group. Upon completion of the final follow-up assessment, participants in this arm will be offered the opportunity to receive the full intervention program (wait-list design).

Standard Care

Eligibility Criteria

Age18 Months - 80 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Meets the criteria for being at high-risk for colorectal cancer as defined by the US National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colorectal Cancer Screening and the relevant Chinese expert consensus on colorectal cancer diagnosis and treatment.
  • Age ≥ 18 years.
  • Has normal verbal communication and comprehension abilities.
  • Provides informed consent and voluntarily agrees to participate in the study.

You may not qualify if:

  • Has a prior diagnosis of any malignancy (cancer).
  • Has a diagnosed severe psychiatric or psychological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Nursing, China Medical University

Shenyang, Liaoning, 110122, China

RECRUITING

MeSH Terms

Conditions

Health BehaviorColorectal Neoplasms

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

BehaviorIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Researcher, School of Nursing, China Medical University

Study Record Dates

First Submitted

November 19, 2025

First Posted

December 4, 2025

Study Start

November 10, 2025

Primary Completion

February 10, 2026

Study Completion

February 10, 2026

Last Updated

December 4, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

What IPD will be shared? Individual participant data that underlie the results reported in the primary and secondary publications after de-identification. This will include demographic data, baseline characteristics, and all outcome measure scores (e.g., HPLP-HRCP, CRC-KQ, CHBMS, MHLC, K10, PSSS). When will IPD be available? Beginning 9 months after the publication of the main trial results and ending 36 months thereafter. Who can access the IPD?? Researchers who provide a methodologically sound proposal for use in an independent ethical review-approved meta-analysis or replication study. How can IPD be accessed? Proposals should be directed to the corresponding author via email. To gain access, requestors will need to sign a data access agreement. Data will be shared via a secure file transfer platform. What other documents will be available? The study protocol, statistical analysis plan, and informed consent form will be made available on ClinicalTrials.gov alongside the results.

Locations